The most commonly used test for monitoring heparin therapy is the activated partial thromboplastin time (aPTT). The performance of available aPTT reagents varies significantly. The aim of this study was to assess the suitability of dried aPTT reagents for the purpose of monitoring unfractionated heparin dose-response in diagnostic devices. Ten reagents were analysed in terms of their performance in liquid and in dried form after 24 h and 14 days. The ability to reduce the natural plasma clotting time (CT) and their sensitivity to heparin was assessed. The thrombin generation assay was the method of choice. All reagents resulted in significant reductions in CT. Liquids returned more rapid CTs in comparison to dried reagents. Most reagents were more sensitive to heparin in dried, rather than in liquid form. Dried reagents based on kaolin as a surface activator were notably more effective in achieving rapid CT, while reagents composed of silica and synthetic phospholipids were the most sensitive to heparin. Identification of the most suitable aPTT assay reagent for incorporation into a diagnostic device platform was achieved based on dried reagent stability and responsiveness to heparin. (Khandurina and Guttman, 2002) . There is an increasing requirement for reliable point-of-care devices for monitoring the effect of drugs which regulate blood coagulation (Khan, 2009 ). This in turn leads to an increased demand for highly concentrated and optimized formulations of active ingredients capable of inducing a rapid clotting response in a low volume test sample. Since the first application of partial thromboplastin time (aPTT) for monitoring anticoagulant therapy (Struver and Bittner, 1962) , it has become the most popular test for heparin dose monitoring (Gawoski et al., 1987) and is regarded as the most reliable and commonly used test (Kitchen et al., 1996) for heparin dosage adjustment in long term therapy and pre-thrombotic monitoring (Bowers and Ferguson, 1993) . There have been several automated devices developed to monitor aPTT, e.g. the CoaguCheck ® Pro. In general, such devices contain dry formulations that selectively induce the clotting process. The accuracy and reliability of the results are highly influenced by the quality of the dried chemistry. There are a growing number of ready-to-use aPTT reagent kits available in liquid or lyophilized forms. A number of studies have identified that aPTT reagents vary significantly in their responsiveness to heparin (Kitchen et al., 1999 , Banez et al., 1980 . Different aPTT reagents often return different aPTT values with normal patient plasmas. There is an urgent need for the standardization of aPTT-based monitoring systems for heparin therapy in clinical settings (Poller et al., 1989 , Kitchen et al., 1996 . The varying responsiveness of aPTT reagents is dependent upon the composition of particular constituents of the formulation. These contain animal or plant extracts as sources of phospholipids (partial thromboplastin) combined with a surface activator such as kaolin, factor XII which is the first step of the contact activation pathway leading to the eventual formation of the insoluble fibrin clot (Griffin and Cochrane, 1979) . Both, the source and the concentration of phospholipids have been highlighted as important factors in assay behaviour, e.g. a decreased phospholipid concentration can lead to an increased heparin sensitivity of the reagent (Ts'ao et al., 1998 , Kitchen et al., 1999 .
Stevenson et al. documented that the lipid phase concentration may differ by 300 times between some commercially available aPTT reagents (Stevenson et al., 1986) .
Advances in technology have led to the development of recombinant materials for use in coagulation assays. Such defined and reproducible materials might help to control the variation that exists within aPTT activated clotting response (Barrowcliffe and Gray, 1981, Triplett, 1982) . Several reports provide a detailed characterization of aPTT reagents (Stevenson et al., 1991 , Kitchen et al., 1999 , Martin et al., 1992 . These are extremely informative sources of data on aPTT reagent composition and performance in clinical and laboratory settings. The differences in their sensitivity to heparin and lupus antibodies have been shown (Eby, 1997 , Manzato et al., 1998 . However, there is very little data regarding the use of available aPTT formulations for the purpose of diagnostic device development. Due to a wide variety of aPTT products with different formulations and physical characteristics, an assessment of the aPTT performance in dried form and its stability upon prolonged storage time was needed. Evaluation of the dried-surface reagents would allow selection of the most suitable activators to be incorporated into a coagulation monitoring assay. The effect of resolubilization and drying on their activity is of particular relevance. The thrombin generation assay (TGA) was chosen as a tool for the comparison of the ability of aPTT reagents to reduce natural plasma clotting time (CT) by measuring the rate of thrombin generation (van Veen et al., 2008) . This study includes a comparison of a variety of aPTT formulations in (i) liquid, (ii) 24 h dried and (iii) 14 days dried forms.
These were analysed in terms of their ability to reduce plasma CT, stability upon prolonged exposure to ambient conditions and responsiveness to heparin. 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59 plates and left to dry under ambient laboratory conditions. The dried reagent was reconstituted in 50 µL of water prior to analysis. Thrombin generation profiles for dried reagents at 24 h and 14 days were compared to those for liquid controls.
Reagents were analysed in terms of their sensitivity to heparin using spiked plasma samples. It has been shown that the response from ex vivo samples from patients on heparin therapy differs from in vitro plasma samples spiked with heparin (Jespersen et al., 1999 , Van den Besselaar et al., 1990 . However, heparin-spiked samples were used herein for the purpose of a performance comparison between reagents and not for the aPTT clinical reference standardization. Control plasma was spiked with heparin so that the final concentration in plasma was between 0 and 2 U/mL.
Data Analysis
The activity of the aPTT reagents was determined by their ability to reduce the natural plasma CT. Three methods of CT calculation were employed which were (i) the length of the lag time (LT), which was taken as the time prior to the occurrence of the thrombin burst (observed as a rapid increase in the measured absorbance) followed by a propagation phase (Wolberg, 2007) , (ii) the area under the curve (AUC) and (iii) the time-to-peak (TTP). AUC was calculated from both raw (absorbance vs time) and differentiated (dAbs vs time) data. This reflects the total time for which thrombin exerts its enzymatic activity and is related to the endogenous thrombin potential. TTP was taken as the time point where the response profile reached a plateau and the increase in absorbance ceased. This is related to initiation of thrombin production and propagation and corresponds to the time required for the available substrate to be utilized (Wolberg, 2007) . Analysis of these characteristic response profiles led to the determination of CT based on LT. CT values were related to heparin concentration and the resulting correlations provided useful information about the dry and liquid reagent sensitivity to heparin. Inter-and intra-assay variation (CV) was also determined. 
RESULTS
Clotting time extraction. Fig. 1 shows typical thrombin generation profiles for human plasma samples with and without activation by Cephalinex aPTT reagent. The thrombin generation profile of the blank control showed a LT greater than 1500 s, a rapid increase in absorbance and a plateau at about 2500 s. In most assays, corn trypsin inhibitor is added to prevent controls from clotting. However, as a control to assess the level of inter-assay variability, non-activated controls were used (Lo et al., 2005) . The average control plasma LT for all assays was found to be 1943 s with a %CV of 15.6%. 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59 
Addition of liquid

Comparison of aPTT reagent activities in liquid and dried forms
It has been established in many studies that commercially available aPTT reagents are effective for plasma CT reduction in their liquid form. However, an important parameter from the point of view of bioassay development is that reagents need to maintain their pro-coagulant properties upon long-term storage in a dehydrated state. The performance of aPTT reagents in their liquid and 24 h / 14 day dried forms was assessed by TGA according to their CT values ( Fig. 3 ).
Fig. 3.
As expected, the performance of all aPTT reagents in their liquid forms was excellent.
The liquid state was recommended by manufacturers to be used for plasma CT assays.
CT values between 41 ±12.8 s for C.K. Prest 2 and 161 ±23.8 s for SynthASIL were obtained. In addition to comparisons of reagent activity in their liquid forms, the stability of the ready-to-use formulations was also assessed following drying and maintained at ≤ 15% for all tested reagents (n = 5), while significant differences in the inter-assay variability (n = 3) was noticed. It was observed that reagents that were more affected by the storage time and conditions, resulting in a prolonged CT (in comparison to a liquid control) were also the least precise (highest %CV for between-assay variability). These were Platelin LS, Alexin, aPTT-P and aPTT-SA which yielded CTs of 1566 s (26.5%), 850 s (15.4%), 438 s (30.9%) and 314 s (40.5%) respectively. The remaining six reagents resulted in CTs < 300 s and %CV of less than 15%.
Heparin sensitivity
A striking variation in aPTT reagent sensitivity to thrombin inhibitors such as heparin has been documented (Greaves, 2004) . Performance of aPTT reagents is highly dependent on the source and content of phospholipids as well as on the type and concentration of surface activator that is supposed to serve a large surface area for stimulation of kallikrein-like activity and initiation of coagulation. Several studies have reported the association of aPTT reagent composition with variations in clotting efficacy (Smeets et al., 1996 , Neuenschwander et al., 1995 and responsiveness to anticoagulant dosage (Ip et al., 2001 , Kitchen et al., 1996 . Herein, the effect of the drying process and storage of the aPTT reagents was also evaluated for its effect on the response to heparin in the TGA. Such data is of great importance for the development of miniaturized systems for anticoagulant therapy monitoring.
The effect of heparin addition (0 -2 U/mL) on plasma CT triggered by all ten aPTT reagents in their liquid and dried forms was evaluated by TGA. Reagent sensitivity to heparin was assessed on the basis of the derived calibration curves. For example, the 
DISCUSSION
Very good linear correlations between CT and heparin concentration were found for nine out of the ten tested reagents within the heparin range of 0 -2 U/mL (R 2 ≥ 0.83).
Platelin LS was the only reagent on which the drying process had a dramatic negative impact resulting in significant loss of activity. High variation and no correlation with increased heparin concentrations were also found for the 14 day dried samples (R 2 = 0.02). Even though most of the reagents tested responded to addition of heparin by returning prolonged CTs, the deterioration of control clotting values (base CT) also had to be taken into account when selecting a stable, dry formulation which was responsive the reagent composition is one of the most commonly cited (Manzato et al., 1998 , Shetty et al., 2003 , Wojtkowski et al., 1999 . The available surface area of the negatively charged surface activators might be reduced due to dehydration following drying. The surface activation may be influenced by the type of activator used. Drying processes may have influenced the orientation and distribution of phospholipids. Some classes of phospholipids are of particular importance, and depending on their ratios and the total concentration of lipids, clotting can be promoted or inhibited (Slater et al., 1980 , Comfurius et al., 1994 . Liquid reagents containing phospholipids derived from rabbit brain cephalin (C.K. Prest 2, aPTT-P, aPTT-SA and Alexin) returned the shortest CTs varying between 41 -85 s. However, their ability to reduce plasma CT was significantly impacted by the drying process. The chicken and porcine-derived phospholipids used in Platelin LS gave an extremely prolonged CT in dried form (up to 1566 s for 14 days dried reagent). APTT-SP (silica and synthetic phospholipids) was the only reagent for which the absolute CT did not increase after 24 h following drying.
However, prolonged storage under ambient conditions did result in the reagent's eventual deterioration. Another reagent which performed reasonably well was Cephalinex (containing silica activator and rabbit brain phospholipids). Despite the fact that the 24 h drying did influence the reagent's ability to shorten plasma CT, the long term storage did not seem to affect its activity. However, Cephalinex was shown to be less sensitive to heparin than aPTT-SP in all three tested forms.
It has been also shown that the type and concentration of surface activator plays a major role in the effectiveness of aPTT reagents (Marlar et al., 1984) . Reagents based on 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59 The combination of traditionally-used kaolin and rabbit brain cephalin extract (C.K.
Prest 2) seemed to achieve rapid CTs. However, it should be taken into account that the use of insoluble particulates such as kaolin or silica for automated devices employing photo-optical detection may be problematic. The use of a soluble ellagic acid or a mixture of low concentration insoluble activators such as kaolin and sulfatides i.e.
Dapttin (Moritz and Lang, 1995) may be a solution for devices based on optical detection systems.
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